{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "multicenter double-blind parallel group randomized superiority trial"
      },
      "Participants": {
        "score": 2,
        "evidence": "patients\u2009\u2265\u200918\u00a0years undergoing elective esophagectomy, gastrectomy, colectomy, rectal resection, pancreatic resection, or hepatectomy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "compare tranexamic acid (loading dose 1000\u00a0mg over 10\u00a0min prior to skin incision, maintenance dose 125\u00a0mg/h continuously until skin closure or until 1000\u00a0mg have been administered) to placebo"
      },
      "Objective": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary efficacy endpoint is the intra- or postoperative transfusion of at least one unit of packed red blood cells."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 2,
        "evidence": "double-blind"
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "425 patients are to be randomized per group"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: EU CT Nr: 2023\u2013509970-43\u201301, NCT06414031"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 13,
    "max_score": 25
  },
  "model": "gpt-4o"
}